PAIYY — Aesthetic Medical International Holdings Balance Sheet
0.000.00%
- $10.04m
- $30.61m
- CNY755.67m
- 56
- 92
- 26
- 61
Annual balance sheet for Aesthetic Medical International Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 44.4 | 39.3 | 12.2 | 62.3 | 42.8 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 120 | 43.9 | 35 | 33.7 | 29.3 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 206 | 114 | 77.6 | 112 | 88.1 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 532 | 359 | 344 | 327 | 301 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,038 | 577 | 546 | 561 | 486 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 302 | 542 | 544 | 411 | 402 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 647 | 734 | 660 | 512 | 456 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 391 | -157 | -114 | 48.9 | 30.5 |
| Total Liabilities & Shareholders' Equity | 1,038 | 577 | 546 | 561 | 486 |
| Total Common Shares Outstanding |